Mohamed Nabil Elshafei
Mohamed Nabil Elshafei publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases, on topics such as Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management and COVID-19 Clinical Research Studies.
- World rank
- #3,541,088 of 7,710,434 ranked researchers
- Rank in Qatar
- #2,003 of 3,423
- Works
- 67
- Citations
- 675
- Citations per work
- 10.1
What does Mohamed Nabil Elshafei research?
Mohamed Nabil Elshafei's work is mostly in Medicine (50%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3450.0%
- Medicine3450.0%
- Everything else3450.0%
- 1Cardiology and Cardiovascular Medicine15% of their works
- 2Surgery12% of their works
- 3Infectious Diseases7% of their works
- 4Hepatology6% of their works
- 5Internal Medicine5% of their works
- 6Epidemiology5% of their works
Research topics
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- COVID-19 Clinical Research Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Inflammasome and immune disorders
- Antiplatelet Therapy and Cardiovascular Diseases
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver Disease Diagnosis and Treatment
Which keywords describe Mohamed Nabil Elshafei's research?
The keywords of their largest research topics: Diagnosis, Treatment, Epidemiology, Immune Response, Hepatocellular Carcinoma, Anticoagulant Therapy, Antithrombotic Therapy and Atrial Fibrillation.
- NAFLD
- Inflammasome
- Cholangiocarcinoma
- Aspirin
- Liver Cancer
- Clinical Characteristics
- Atrial Fibrillation
- Anticoagulant Therapy
- Immune Response
- Treatment
- Diagnosis
- Epidemiology
- Hepatocellular Carcinoma
- Antithrombotic Therapy
- Venous Thromboembolism
- SARS-CoV-2
- Management
- Biliary Tract Cancer
- Clopidogrel
- NLRP3
- NASH
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Diagnosis172 topics
- Treatment172 topics
- Epidemiology132 topics
- Immune Response132 topics
- Hepatocellular Carcinoma112 topics
- Anticoagulant Therapy101 topic
- Antithrombotic Therapy101 topic
- Atrial Fibrillation101 topic
- Venous Thromboembolism101 topic
- Clinical Characteristics81 topic
- SARS-CoV-281 topic
- Liver Cancer71 topic
- Management71 topic
- Aspirin51 topic
- Biliary Tract Cancer51 topic
- Cholangiocarcinoma51 topic
- Clopidogrel51 topic
- Inflammasome51 topic
- NLRP351 topic
- NAFLD41 topic
- NASH41 topic
Where does Mohamed Nabil Elshafei work?
Mohamed Nabil Elshafei's main affiliation in the publication record is Hamad Medical Corporation, Qatar.
How many publications and citations does Mohamed Nabil Elshafei have?
OpenAlex counts 67 works and 675 citations for Mohamed Nabil Elshafei, an h-index of 14, ranking #3,541,088 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mohamed Nabil Elshafei. Posts are plain text and can be reported.